Dr. Boyeon Kim, Managing Director at Invites Genomics, shared her enthusiasm for joining the genome project IPMI (Invites Precision Medicine Initiative) to deepen our understanding of the Korean population. She also offered valuable insights into sequencer selection, emphasizing the importance of high-throughput and data quality stability. She remarked that DNBSEQ-T7 meets these rigorous standards to help their research.